# A Study Investigating the Safety of RO7795081 and How the Body Processes RO7795081 in People With Normal or Decreased Kidney Functions

> **NCT07741604** · PHASE1 · RECRUITING · sponsor: **Hoffmann-La Roche** · enrollment: 60 (estimated)

## Conditions studied

- Renal Impairment

## Interventions

- **DRUG:** RO7795081

## Key facts

- **NCT ID:** NCT07741604
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-09-09
- **Primary completion:** 2028-02-01
- **Final completion:** 2028-02-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07741604

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07741604, "A Study Investigating the Safety of RO7795081 and How the Body Processes RO7795081 in People With Normal or Decreased Kidney Functions". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07741604. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*